Public Plans
Public plans are plans created using the DMP Tool service and shared publicly by their owners. They are not vetted for quality, completeness, or adherence to funder guidelines.
Plans (120)
NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)
Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SVOCs) on Neonatal and Early Childhood Immune Function
Jennifer Hoffman, Duke University (duke.edu)
NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)
Unraveling the Complexities of Risk and Mechanism in Cancer
John Quackenbush, Harvard University (harvard.edu)
NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)
Scientific and Public Outreach of Cell Type Taxonomies (SPOCTT) Initiative 2.0
Julie Nyhus, Allen Institute for Brain Science (alleninstitute.org)
NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)
Law Enforcement Drug Seizures and Homeless Encampment Displacements: Implications for Overdose Risk
Bradley Ray, RTI International (rti.org)
NIH-Default DMSP
Increasing Trial Enrollment of Rural Residents in ARDS Clinical Trials
Marie Nguyen, University of Nebraska Medical Center (unmc.edu)
NIH-Default DMSP
Psychotropic compounds from wastewater contamination affect nervous system development
Dena Weinberger, Murray State University (murraystate.edu)
NIH-Default DMSP
DMSP for "Efficient Red-To-Nir Photo-Uncaging and Applications in Therapy"
Cristo Yanez leon, New Jersey Institute of Technology
NIH-GEN DMSP (Forthcoming 2023)
Rhode Island IDeA Network of Biomedical Research Excellence April 2024
Christopher Hemme, University of Rhode Island (ww2.uri.edu)
NIH-Default DMSP
Increasing Trial Enrollment of Rural Residents in ARDS Clinical Trials
Dustin Krutsinger, University of Nebraska Medical Center (unmc.edu)
NIH-Default DMSP
Neurochemical and neurophysiological underpinnings of psilocybin-mediated attenuation of chronic pain
Sara Smith, University of Michigan (umich.edu)
